|
TRMT61B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.157100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.623200E-04 |
| Normal-vs-Stage2 |
2.115400E-01 |
| Normal-vs-Stage3 |
2.502300E-02 |
| Normal-vs-Stage4 |
4.579900E-03 |
| Stage1-vs-Stage2 |
4.075200E-01 |
| Stage1-vs-Stage3 |
8.424800E-01 |
| Stage1-vs-Stage4 |
5.283200E-01 |
| Stage2-vs-Stage3 |
5.897400E-01 |
| Stage2-vs-Stage4 |
2.949200E-01 |
| Stage3-vs-Stage4 |
4.702000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.715370E-03 |
| Normal-vs-AfricanAmerican |
1.595660E-03 |
| Normal-vs-Asian |
7.649800E-01 |
| Caucasian-vs-AfricanAmerican |
4.282400E-01 |
| Caucasian-vs-Asian |
5.032200E-01 |
| AfricanAmerican-vs-Asian |
2.777400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.589540E-04 |
| Normal-vs-Female |
1.533430E-01 |
| Male-vs-Female |
2.334100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.197550E-03 |
| Normal-vs-Extreme_Weight |
1.413600E-04 |
| Normal-vs-Obese |
7.736400E-03 |
| Normal-vs-Extreme_Obese |
1.460050E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.900400E-01 |
| Normal_Weight-vs-Obese |
4.131000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.281400E-01 |
| Extreme_Weight-vs-Obese |
4.042600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.523600E-01 |
| Obese-vs-Extreme_Obese |
7.953200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.557200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.781600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.700660E-03 |
| Normal-vs-Age(81-100Yrs) |
3.841500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.563800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.637570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.372300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.397000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.670600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.461400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.881600E-03 |
| Normal-VS-Type2 PRCC |
4.614900E-04 |
| Normal-VS-KIRP CIMP |
5.204000E-01 |
| Normal-VS-Unclassified PRCC |
3.217800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.644400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.155800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.189000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.043600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.632000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.259800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.633500E-04 |
| Normal-vs-N1 |
5.885200E-01 |
| Normal-vs-N2 |
2.584400E-01 |
| N0-vs-N1 |
1.416800E-01 |
| N0-vs-N2 |
6.120000E-01 |
| N1-vs-N2 |
3.468800E-01 |
|
|
